During Tuesday’s Current trade, Shares of PennyMac Mortgage Investment Trust (NYSE:PMT), lost -1.01% to $15.71.
The Board of Trustees of PennyMac Mortgage Investment Trust (PMT) declared a cash dividend of $0.47 per common share of beneficial interest for the third quarter of 2015. This dividend will be paid on October 29, 2015 to common shareholders of record as of October 15, 2015.
PennyMac Mortgage Investment Trust, a specialty finance company, invests primarily in residential mortgage loans and mortgage-related assets in the United States. The company operates through two segments, Correspondent Production and Investment Activities.
Shares of Arista Netoperates Inc (NYSE:ANET), declined -1.17% to $61.48, during its current trading session.
Arista Netoperates (ANET) declared a new portfolio of data center switches that address the demand for 25/50/100GbE switching. Arista EOS (extensible operating system) features such as Smart System Upgrade with hitless software upgrades, hitless speed change and network rollback, provide customers with non-stop operational tools for building cloud scale netoperates.
Arista Netoperates, Inc. provides cloud networking solutions. The company offers extensible operating systems, a set of network applications, and Ethernet switches. It serves a range of industries, counting Internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, and others. Arista Netoperates, Inc. markets its products through direct sales force and channel partners, such as distributors, value-added resellers, systems integrators, and original equipment manufacturer partners.
Five Prime Therapeutics Inc (NASDAQ:FPRX), during its Tuesday’s current trading session decreased -2.22% to $15.39.
Five Prime Therapeutics, Inc. (FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, recently declared that Lewis T. “Rusty” Williams, M.D., Ph.D., President and Chief Executive Officer, will present at the Leerink Partners Inaugural Immuno-Oncology Roundtable on Thursday, October 1, 2015 at 1:05 PM Eastern Daylight Time. The conference will take place at the Le Parker Meridien Hotel in New York City.
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes.
Finally, Box Inc (NYSE:BOX), decreased -3.32%, to $11.92.
Canon Information and Imaging Solutions, Inc. (CIIS), a wholly owned partner of Canon U.S.A., Inc., declared a partnership with enterprise content administration and partnership platform BOX (BOX). The partnership brings together Canon’s imaging and cloud technologies with Box’s rich platform capabilities to offer integrated solutions for vertically targeted industries, such as government, non-profit, healthcare, retail, legal and financial services.
The partnership will focus on the integration of Canon’s portfolio of document imaging solutions with the Box platform to enable businesses to securely collaborate and easily manage content in Box. In addition, with an eye toward the future, both companies will look beyond the office to explore opportunities in industries such as healthcare, surveillance, and entertainment.
Box, Inc. provides a cloud-based enterprise content partnership platform that enables organizations of various sizes to access, store, share, and manage their content/information.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
